Clinical epidemiological analysis of 3602 cases of primary liver cancer in Xinjiang

Chinese Journal of Oncology

Volumn 34, Issue 5, 2012, Pages 374-377

  Ni, Ya Qiong ^a   Zhao, Hua Rong ^a   Mao, Rui ^a   Zhang, Hua ^a   Wen, Hao ^a   Xiao, Lei ^a   Tursun, Alie ^a   Bao, Yong Xing ^a  

^a XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

Epidemiology; Hepacivirus; Liver neoplasms; Minority groups; Retrospective studies

Indexed keywords

ARTICLE; CANCER EPIDEMIOLOGY; CHINA; FEMALE; HEPATITIS B VIRUS; HEPATITIS VIRUS; HUMAN; LIVER CANCER; MAJOR CLINICAL STUDY; MALE; VIRUS DETECTION;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; ETHNIC GROUPS; FEMALE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84862550772     PISSN: 02533766     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0253-3766.2012.05.012     Document Type: Article

References (15)

1. Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008; GLOBCAN 2008. Int J Cancer, 2010, 127:2893-2917.
2. Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer, 2006, 118:3030-3044.
3. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA, 2002, 287:356-359.
4. Paradis V, Zalinski S, Chelbi E, et al. Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis; a pathological analysis. Hepatology, 2009, 49:851-859